
|Articles|August 11, 2021
Pharmacy Clinical Pearl of the Day: First-line Treatment Options for Heart Disease
Author(s)Saro Arakelians, PharmD
The goal of treating heart failure is to reduce symptoms, improve heart function, and increase ejection fraction.
Advertisement
Clinical Pearl of the Day:
Heart failure disease first-line treatment options:
- ACE inhibitors/ARB or ARNI (Entresto) and Beta blockers plus aldosterone blockers (for Class II-IV heart failure with GFR>30ml, K+<5)
- SGLT-2 Inhibitor: If volume is overloaded add Loop diuretic
Explanation:
When it comes to heart failure treatment options, patients should be started on beta blockers, ACE inhibitors, ARBs, or ARNIs.
If the dosages are maxed out, patients do not tolerate, or patients do not benefit from these first-line options, then prescribers should be adding aldosterone blockers or SGLT-2 inhibitors
The goal is to reduce the symptoms, improve heart function, and increase ejection fraction.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Pharmacists at the Forefront: Initiating, Monitoring, and Identifying Candidates for VMAT2 Therapy
2
mRNA COVID-19 Booster Outperforms Protein-Based Shot on Antibodies, But Both Cut Infections Over 12 Months
3
FDA Approves Zidesamtinib for Previously Treated ROS1-Positive NSCLC
4
Building a Pharmacist-Led Furoscix Workflow From Scratch
5





































































































